Metronidazole 0.75%; vaginal gel; contains parabens. Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B).

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% ...

The drug is available in several forms: immediate-release oral tablets and capsules extended-release oral tablets topical creams, gels, and lotions vaginal gels The different forms of ...

The generic name of the gel is Metronidazole Vaginal Gel. "Metronidazole vaginal gel is a widely used antibacterial preparation, and its generic version can bring significant savings to the ...

Annual market sales for MetroGel-Vaginal® for the 12 months ending May 2019 were approximately $100 million as measured by IQVIA™. The product is manufactured by Perrigo and was developed ...

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel.

The product, a metronidazole vaginal gel to treat bacterial vaginosis, will compete against 3M Co's MetroGel-Vaginal product. 3M has said MetroGel-Vaginal accounted for about 2 percent of its 2005 ...

Glenmark Pharmaceuticals on Friday said its US-based unit has received approval from the US health regulator to market Metronidazole Vaginal gel, in the American market. The drug firm has received ...

The drug firm has received final approval by the United States Food & Drug Administration (USFDA) for its product which is a generic version of Bausch Health US LLC's MetroGel-Vaginal (Photo ...